N, V., SN, C., L, C., J, C., RS, M., JM, M., . . . SA, C. (2024). An Evidence-Based Update on Anticholinergic Use for Drug-Induced Movement Disorders. CNS drugs, 38(4), 239. https://doi.org/10.1007/s40263-024-01078-z
Chicago Style (17th ed.) CitationN, Vanegas-Arroyave, et al. "An Evidence-Based Update on Anticholinergic Use for Drug-Induced Movement Disorders." CNS Drugs 38, no. 4 (2024): 239. https://doi.org/10.1007/s40263-024-01078-z.
MLA (9th ed.) CitationN, Vanegas-Arroyave, et al. "An Evidence-Based Update on Anticholinergic Use for Drug-Induced Movement Disorders." CNS Drugs, vol. 38, no. 4, 2024, p. 239, https://doi.org/10.1007/s40263-024-01078-z.
Warning: These citations may not always be 100% accurate.